Two Sigma Investments’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.8M | Buy |
1,313,783
+1,261,369
| +2,407% | +$33.4M | 0.06% | 366 |
|
|
2025
Q1 | $1.27M | Buy |
+52,414
| New | +$1.27M | ﹤0.01% | 1987 |
|
|
2024
Q4 | – | Sell |
-51,546
| Closed | -$3.26M | – | 3441 |
|
|
2024
Q3 | $3.26M | Sell |
51,546
-2,136
| -4% | -$135K | 0.01% | 1290 |
|
|
2024
Q2 | $2.85M | Sell |
53,682
-7,164
| -12% | -$380K | 0.01% | 1256 |
|
|
2024
Q1 | $4.99M | Sell |
60,846
-58,100
| -49% | -$4.76M | 0.01% | 925 |
|
|
2023
Q4 | $2.21M | Sell |
118,946
-499,244
| -81% | -$9.29M | 0.01% | 1384 |
|
|
2023
Q3 | $6.84M | Buy |
618,190
+199,016
| +47% | +$2.2M | 0.02% | 716 |
|
|
2023
Q2 | $6.79M | Sell |
419,174
-276,531
| -40% | -$4.48M | 0.02% | 753 |
|
|
2023
Q1 | $11.6M | Sell |
695,705
-569,483
| -45% | -$9.48M | 0.03% | 511 |
|
|
2022
Q4 | $11.9M | Buy |
1,265,188
+278,865
| +28% | +$2.62M | 0.04% | 480 |
|
|
2022
Q3 | $2.68M | Sell |
986,323
-55,679
| -5% | -$151K | 0.01% | 982 |
|
|
2022
Q2 | $3.01M | Sell |
1,042,002
-202,090
| -16% | -$584K | 0.01% | 943 |
|
|
2022
Q1 | $3.73M | Buy |
1,244,092
+310,611
| +33% | +$932K | 0.01% | 1033 |
|
|
2021
Q4 | $4.29M | Buy |
933,481
+57,157
| +7% | +$263K | 0.01% | 963 |
|
|
2021
Q3 | $5.5M | Buy |
876,324
+48,380
| +6% | +$304K | 0.01% | 860 |
|
|
2021
Q2 | $4.96M | Sell |
827,944
-294,887
| -26% | -$1.77M | 0.01% | 925 |
|
|
2021
Q1 | $7.1M | Buy |
1,122,831
+832,611
| +287% | +$5.27M | 0.02% | 704 |
|
|
2020
Q4 | $1.63M | Buy |
290,220
+225,596
| +349% | +$1.27M | ﹤0.01% | 1148 |
|
|
2020
Q3 | $376K | Sell |
64,624
-397,276
| -86% | -$2.31M | ﹤0.01% | 1509 |
|
|
2020
Q2 | $3.33M | Buy |
+461,900
| New | +$3.33M | 0.02% | 693 |
|
|
2019
Q1 | – | Sell |
-389,620
| Closed | -$2.98M | – | 2471 |
|
|
2018
Q4 | $2.98M | Buy |
+389,620
| New | +$2.98M | 0.01% | 903 |
|